Journal
BRAIN BEHAVIOR AND IMMUNITY
Volume 30, Issue -, Pages S68-S74Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2012.07.005
Keywords
Cancer; Hematopoietic stem cell transplantation; Psychoneuroimmunology; Stress; Depression; Immunity; Inflammation; Graft-versus-host disease; Infections; Quality of life
Categories
Funding
- National Cancer Institute [K07 CA136966, R21 CA133343]
- Forward Lymphoma Foundation
Ask authors/readers for more resources
Hematopoietic stem cell transplantation (HSCT) is a rigorous therapy that carries significant risk of morbidity and mortality to individuals with hematologic malignancies undergoing this treatment. While relationships between psychosocial factors, immune function, and clinical outcomes have been documented in other cancer populations, similar studies of cancer patients undergoing HSCT have not yet been conducted. The clinical significance of these relationships may be particularly salient in this population given the critical role of a timely immune recovery and optimal immune regulation in preventing infections, mitigating risk for graft-versus-host disease, and eliminating malignant cells, thereby reducing morbidity and mortality. Evidence for the potential role of biobehavioral processes following HSCT is reviewed, mechanisms by which psychosocial factors may influence immune processes relevant to post-transplant outcomes are discussed, and a framework to ground future psychoneuroimmunology (PNI) research in this area is provided. The review suggests that the recovery period following HSCT may provide a window of opportunity during which interventions targeting stress-related behavioral factors can influence the survival, health, and well-being of HSCT recipients. (C) 2012 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available